<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03947554</url>
  </required_header>
  <id_info>
    <org_study_id>EP-1005</org_study_id>
    <nct_id>NCT03947554</nct_id>
  </id_info>
  <brief_title>Ginseng HRG80 in Stress and Fatigue</brief_title>
  <official_title>Study of the Efficacy of Panax Ginseng Herbal Preparation HRG80 for Prevention and Mitigation of the Symptoms of Stress in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EuroPharma, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Botalys SA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>EuroPharma, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effects of a specific herbal preparation of Panax ginseng in
      preventing symptoms of stress in healthy individuals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      HRG80 is an herbal preparation of Panax ginseng with a higher concentration of bioavailable
      ginsenosides than typical Korean ginseng. This study will test whether HRG80 is effective at
      preventing symptoms of stress, such as fatigue, impaired memory, difficulty in concentration,
      attention deficit, restlessness, and irritation related to daily work situations of healthy
      individuals in comparison to placebo and a standard Pananx ginseng with a lower concentration
      of ginsenosides.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Actual">July 1, 2019</completion_date>
  <primary_completion_date type="Actual">June 15, 2019</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Perceived Stress Scale (PSS) from baseline to the last day of treatment</measure>
    <time_frame>Two weeks</time_frame>
    <description>The Perceived Stress Scale is a psychological instrument for measuring the perception of stress by an individual. Scores from 0-13 indicate low stress, 14-26 is considered moderate stress, and scores from 27-40 indicate high perceived stress. The primary outcome is the change in the baseline PSS score for HRG80 versus standard Panax ginseng and placebo.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Psychological Stress</condition>
  <arm_group>
    <arm_group_label>HRG80 Panax ginseng</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Panax ginseng standardized to 63.4 mg of total ginsenosides taken orally once daily in the morning after a meal.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Panax ginseng</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Panax ginseng standardized to 19.6 mg of total ginsenosides taken orally once daily in the morning after a meal.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo capsule containing brown sugar and rice flour, taken orally once daily in the morning after a meal.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HRG80 Panax ginseng</intervention_name>
    <description>Panax ginseng containing 63.4 mg ginsenosides</description>
    <arm_group_label>HRG80 Panax ginseng</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Panax ginseng</intervention_name>
    <description>Panax ginseng containing 19.6 mg ginsenosides</description>
    <arm_group_label>Panax ginseng</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>800 mg excipient</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals experiencing at least one symptom of stress and fatigue during 8 hours of
             mental work with a computer.

          -  Men and women ages 18-65 (all races and ethnicities)

          -  Able to understand and participate in an 11-week study

        Exclusion Criteria:

          -  Taking medicine or dietary supplements which may have potential effects on cognitive
             function

          -  Consuming more than 1 cup of coffee daily (in the morning).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Areg Hovhannisyan, PhD, Dr Sci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sports Medicine and Anti-Doping Service Republican Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sports Medicine and Anti-Doping Service Republican Centre</name>
      <address>
        <city>Yerevan</city>
        <country>Armenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Armenia</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 9, 2019</study_first_submitted>
  <study_first_submitted_qc>May 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2019</study_first_posted>
  <last_update_submitted>July 2, 2019</last_update_submitted>
  <last_update_submitted_qc>July 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Panax ginseng</keyword>
  <keyword>Red ginseng</keyword>
  <keyword>Korean ginseng</keyword>
  <keyword>Adaptogen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress, Psychological</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

